Price
CHART BY
Frequently asked questions
What is Elanco Animal's market capitalization?
The market capitalization of Elanco Animal is $11.77B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for Elanco Animal?
Elanco Animal's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.405. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Elanco Animal's stock?
Currently, 18 analysts cover Elanco Animal's stock, with a consensus target price of $31.46. Analyst ratings provide insights into the stock's expected performance.
What is Elanco Animal's revenue over the trailing twelve months?
Over the trailing twelve months, Elanco Animal reported a revenue of $5.02B.
What is the EBITDA for Elanco Animal?
Elanco Animal's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $1.03B. EBITDA measures the company's overall financial performance.
What is the free cash flow of Elanco Animal?
Elanco Animal has a free cash flow of $379.00M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Elanco Animal have, and what sector and industry does it belong to?
Elanco Animal employs approximately 9,900 people. It operates in the Health Care sector, specifically within the Biotechnology industry.
What is the free float of Elanco Animal's shares?
The free float of Elanco Animal is 494.55M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $11.77B
- EPS (TTM)
- -$0.405
- Free Float
- 494.55M
- Revenue (TTM)
- $5.02B
- EBITDA (TTM)
- $1.03B
- Free Cashflow (TTM)
- $379.00M
Pricing
- 1D span
- $22.86$23.01
- 52W span
- $18.22$27.97
Analyst Ratings
The price target is $31.46 and the stock is covered by 18 analysts.
Buy
16
Hold
2
Sell
0
Information
Elanco Animal Health, Inc. develops, manufactures, and markets products for pets and farm animals. Its products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, TruCan, AviPro, Baytril, Catosal, Denagard, and Experior. The company was founded in 1954 and is headquartered in Indianapolis, IN.
- Employees
- 9,900
- Industries
- Biotechnology
- Sector
- Health Care
Identifier
- Primary Ticker
- ELAN
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet